# OnCo record sandra-dangelo (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/sandra-dangelo/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "sandra-dangelo" ;
  schema:name "Sandra P. D'Angelo"@en ;
  schema:description "Led SPEARHEAD-1, the trial that made afami-cel the first engineered TCR T-cell therapy approved for a solid tumour."@en ;
  schema:url <https://onco.cc/people/sandra-dangelo/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=D'Angelo%20SP%5BAuthor%5D%20sarcoma%20afamitresgene> ;
  onco:tag "sarcoma", "cell-therapy", "tcr-t" ;
  schema:jobTitle "Medical Oncologist, Sarcoma and Melanoma Services, Memorial Sloan Kettering Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-3736-3783> ;
  onco:cancers <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/merkel-cell-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/mage-a4/> ;
  onco:drugs <https://onco.cc/drugs/afamitresgene-autoleucel/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-spearhead-1-lancet-2024/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .